Purpose: To evaluate the feasibility of using diffusion tensor imaging (DTI) to characterize the temporospatial profile of axonal degeneration and its relation to blood-brain barrier (BBB) permeability. Materials and Methods: Longitudinal DTI was performed in Wallerian degeneration slow (WldS) mice following retinal ischemia. In parallel, gadolinium (Gd)-enhanced T 1 -weighted imaging (Gd-T 1 WI) was performed to evaluate BBB permeability in white matter during axonal degeneration. To confirm the in vivo findings, immunohistochemistry using SMI-31 and myelin basic protein (MBP) was performed to examine the axons and myelin, respectively, and Evans blue was used to evaluate the permeability of the BBB. Results: Reduced axial diffusivity was found in the optic nerve (ON, -15%, P 5 0.0063) 1 week and optic tact (OT, -18%, P 5 0.0077) 2 weeks after retinal ischemia, which were respectively associated with an 11% (P 5 0.0116) and 25% (P 5 0.0001) axonal loss. Increased radial diffusivity was found 1-2 weeks after the colocated decrease of axial diffusivity (35% increase, P 5 0.0388 in the ON at week 2 and an 80% increase, P 5 0.0015 in the OT at week 4). No significant changes were observed using Gd-T 1 WI (P 5 0.13-0.75), although an approximately 1-fold increase in Evans blue staining intensity was found in the injured ON and OT starting 1 week after retinal ischemia. Conclusion: We demonstrated the utility of DTI to characterize anterograde-propagating axonal degeneration through the ON and OT following retinal damage. Evans blue staining revealed serum albumin accumulation at injured sites, although there was no BBB leakage detectable using Gd-T 1 WI. Level of Evidence: 2
A xonal degeneration is a common feature of many neurological diseases. 1, 2 Damage to neuronal cell bodies or axons may trigger axonal degeneration, which can precipitate secondary degeneration along axons toward remote sites. Distinct patterns of degeneration exist and may depend on the types of nerve fibers and initial causes of damage. [3] [4] [5] Use of noninvasive tools to characterize patterns of degeneration in disease may provide useful insights into disease course and pathogenesis. Diffusion tensor imaging (DTI) is a clinically available imaging tool that is sensitive to white matter disruption, including damage to axons. 6, 7 Although several studies have used DTI to characterize axonal degeneration, [8] [9] [10] [11] most studies were conducted in humans, with a lack of histological data to confirm the in vivo findings. Furthermore, no studies have yet systematically collected data from multiple locations along fiber tracts during degeneration, making it difficult to derive a spatial profile of axonal degeneration. It is therefore critical to utilize animal models, with histological follow-up, to evaluate the feasibility of using DTI to characterize the temporospatial profile of axonal degeneration. Among neurological diseases, axonal degeneration in multiple sclerosis (MS) is especially critical, as it may lead to permanent disability of patients who initially were in relapsing-remitting status. 12 In MS, gadolinium (Gd)-enhanced T 1 -weighted magnetic resonance imaging (Gd-T 1 WI) is routinely used to detect inflammation. [13] [14] [15] However, focal inflammatory damage in white matter may trigger axonal degeneration, which can spread degenerating lesions to remote sites in the brain. [16] [17] [18] It is not certain whether the BBB remains intact in regions remote from initial inflammation, considering that cellular debris removal and proinflammatory cytokines may take place as a result of local axonal degeneration. 19, 20 Although studies support the idea that white matter with axonal degeneration does not show enhancement on Gd-T 1 WI, 21, 22 data with supportive evidence are limited. It is therefore of interest to use an animal model to explore the changes in BBB permeability using Gd-T 1 WI in parallel with DTI during white matter axonal degeneration. The purpose of this study is to evaluate the feasibility of using DTI to characterize the temporospatial profile of axonal degeneration and to understand its relation to BBB permeability.
Materials and Methods

Animal Groups and Treatment Methods
This study was conducted in accordance with National Institutes of Health Guidelines and Statement for the Use of Animals in Ophthalmic and Visual Research, and was approved by the Institutional Animal Care and Use Committee. Twenty-eight 8-week-old female Slow Wallerian Degeneration (WldS) mice were used. Transient retinal ischemia was performed on the right eye of each mouse. The detailed procedure was described previously. 6, [23] [24] [25] In brief, animals were anesthetized by 1.5% isoflurane/oxygen using an isoflurane vaporizer (Vet Equip, Pleasanton, CA). The body temperature was maintained using an electric heating pad under a dissecting microscope. A 30G needle was connected to a saline reservoir hung 1.5 m above the operating table. This needle was inserted into the vitreous space of the right eye for 1 hour. The left eyes were left intact to serve as the internal control for each animal.
MRI-DTI
Seven mice were used for longitudinal DTI evaluation. Imaging was performed 3 days and 1, 2, and 4 weeks after retina ischemia. Animals were anesthetized using 1.5% isoflurane/oxygen using an isoflurane vaporizer (Vet Equip, Pleasanton, CA). Core body temperature was maintained by a circulating warm water pad. The mouse was placed in a holder to immobilize the head. A 7-cm inner volume coil was used as a transmitter coil and a 1.5-cm inner diameter surface coil was used as a receiver to collect data on a Bruker (Billerica, MA) BioSpec 4.7T small-animal MRI instrument. . Field of view was 1.5 3 1.5 cm, and the matrix of 128 3 128 was zero-filled to 256 3 256. Thirteen contiguous slices with 0.5 mm thickness were collected to cover optic nerves and tracts. 26 Data were collected three
times. An ordinary-least-squares method was used to derive tensors on a voxel-by-voxel basis using software written in MatLab (MathWorks, Natick, MA). 27 The eigenvalues (k 1 , k 2 , and k 3 ) of diffusion tensors were used to calculate axial diffusivity (k k ), radial diffusivity (k ? ), relative anisotropy (RA), and trace of the diffusion tensor (Tr) defined by the following equations:
Gd-T 1 WI
Omniscan (gadodiamide, GE Healthcare, Milwaukee, WI) was mixed with saline (lactated Ringer's injection, USP) and heparin (heparin sodium injection, USP) in a 1:2.5:2.5 ratio. A triple dosage of Gd solution (0.3 mmol/kg or 90 ll injection for a 25 g mouse) was injected via a tail vein. At 1 and 4 weeks following retinal ischemia, seven mice were anesthetized and placed in a holder to immobilize the head. The 4.7T MRI, which was used for DTI collection, was not available for use, so a 3-cm volume coil was used to collect data in a Bruker 11.7T small animal MRI instrument. T 1 WIs were collected using a spin-echo sequence with TR 500 msec and TE 14.5 msec. Nine contiguous slices were gathered with slice thickness of 0.75 mm to cover the left and right optic nerves and tracts. Field of view was 1.5 3 1.5 cm, and the matrix of 128 3 128 was zero-filled to 256 3 256. T 1 WIs were acquired before and 5 minutes after the Gd injection. In addition to T 1 WIs, a T 2 -weighted rapid acquisition with refocused echoes (RARE) with TR 1 second, echo train 4, and effective TE of 28 msec were collected with geometric parameters matching T 1 WIs to provide images to visualize the ON and OT. 28 
Region of Interest (ROI) Analysis
From our DTI data, ROIs including the ON and OT were selected manually using RA and k ? maps. The ON and OT appear bright on RA and dark on k ? in comparison to neighboring cerebrospinal fluid (CSF) and gray matter. In both healthy and injured conditions, the intensity contrast remained suitable for ROI selections ( Fig. 1 ). For Gd-T 1 WI measurements, selections were performed using RARE images collected immediately prior to the Gd-T 1 WI scan. Using RARE images, white matter from the ON and OT was identified based on intensity contrast, with white matter appearing darker than surrounding gray matter and CSF. For each ROI, only the central portion of the ON and OT was selected. For the ON, ROIs were selected from the central 2 3 2 to 3 3 3 portion of voxels. Each ON measurement is composed of selections from two contiguous slices. For the OT, the central 25-30 voxels were selected. ROI analysis was performed in a blind fashion by J. Mei and C. Nishioka; both have more than 3 years of experience in mouse brain imaging. 27, 29, 30 Evans Blue Assessments
Mice at 1, 2, and 4 weeks after retinal ischemia (n 5 7) received a tail vein injection at a dosage of 1 mL/kg of 2% Evans blue tracer (E-2129, Sigma, St. Louis, MO) dissolved in normal saline. One hour after the injection, animals were anesthetized and transcardially perfused with phosphate-buffered saline (PBS) followed by formalin. The brains were quickly removed, postfixed for 1 hour, then sunk in 30% sucrose. Brain blocks were snap-frozen in dry ice. For each mouse brain, 2-mm blocks anterior and posterior to Bregma were cut for sections of optic nerve and optic tracts, respectively. Cryostat sections with 20-lm thickness were prepared for fluorescent microscopy. An Olympus FluoView Confocal microscope with laser wavelength of 620 nm was used to examine the brain sections. The Evans blue extravasation was quantified by measuring signal intensity using ImageJ software (NIH, Bethesda, MD).
Immunohistochemistry of SMI-31, MBP, and Iba1
A 4-mm-thick coronal section (-1 to 1 3 mm of Bregma) was obtained from each brain and embedded in paraffin. 26 Under a microscope, images were taken from the central portions of the left and right ON and OT, respectively. The positively labeled axons were counted through the central 100 3 100 lm 2 region.
(ANOVA) followed by the post-hoc Holm-Sidak test. Data analysis was conducted using Sigma Plot 11.0 (San Jose, CA). P < 0.05 was considered statistically significant.
Results
In Vivo DTI Findings
The ROI measurements from the ON and OT after retinal ischemia are summarized in Fig. 2b . In the ON, k k decreased 15% (P 5 0.0063) at 1 week and gradually reached a 30% reduction (P < 0.0016) by 4 weeks. The changes in k k were delayed in the OT, which did not show significant changes at 1 week. The reduction was significant beginning at 2 weeks, with a decrease in k k of 18% (P 5 0.0077), with a reduction of k k reaching 25% (P 5 0.0001) at 4 weeks. The increase of k ? was found 1-2 weeks after the colocated decrease of k k . In the ON, k ? did not show a significant change at 1 week, but increased 35% (P 5 0.0388) at 2 weeks and gradually increased 80-90% (P < 0.0442) above control levels after 3-4 weeks. In the OT, no significant changes in k ? were observed before 3 weeks. However, an 80% increase of k ? (P 5 0.0015) was measured 4 weeks after retinal ischemia. The injured ON and OT (black bars) showed gradual decreases in RA and k k , and gradual increases in k ? relative to controls. The changes in ON occur 1-2 weeks before changes manifest in the OT. The value unit for k k , k ? , and TR is lm 2 /s. RA is unitless. *Significant differences with P < 0.05, compared with the controls.
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February 2017FIGURE 3: SMI-31 immunohistochemistry in the ON and OT after retinal ischemia. The density of SMI-31-positive axons (axon counts in 100 3 100 lm 2 ) is summarized in the bar graphs (right, n 5 7). *Significant changes with P < 0.05. The right ON and left OT showed degeneration as gradual loss of SMI-31 examined at 1, 2, and 4 weeks after retinal ischemia. The loss of axons was significant in the ON beginning at week 1, but gained significance in the OT after 2 weeks. 
Immunohistochemistry of SMI-31 and MBP
The immunohistochemical examination using SMI-31 showed that axonal density was reduced by 11% (P 5 0.0116), 23% (P 5 0.0003), and 41% (P 5 0.0013) in the injured ON at 1, 2, and 4 weeks after retinal ischemia, respectively. In the OT, axonal density was not changed after 1 week, but was reduced by 9% (P 5 0.0056) and 39% (P 5 0.0091) at 2 and 4 weeks after retinal ischemia (Fig.  3) . The immunohistochemical examinations using MBP showed no significant changes in the ON and OT before 1 and 2 weeks after retinal ischemia, but showed 30% reduction (P 5 0.0001 in ON and P 5 0.0086 in OT) of myelinated axon counts in both regions of WldS mice 4 weeks after retinal ischemia (Fig. 4) .
Gd-T 1 WI
There was no noticeable signal enhancement in the brain after Gd-T 1 WI at any timepoint after retinal ischemia (Fig. 5) . Our There was no noticeable enhancement in the brain, including either in the ON or OT (e). Noticeable enhancement was found in several regions outside the brain, including the pharyngeal wall, which showed a 4-6-fold enhancement over baseline (e). *P < 0.05.
ROI analysis found no changes in enhancement within the injured ON and OT compared to controls. Outside the brain, noticeable enhancement was present in several regions, including the pharyngeal wall, which showed a 4-6-fold increase (P 5 0.0001) in signal enhancement (Fig. 5d ).
Evans Blue Staining
As shown in Fig. 6 , the injured ON and OT showed a 1-2-fold increase in staining intensity compared to controls beginning 1 week after retinal ischemia. These differences were statistically significant in the damaged ON at 2 weeks and damaged OT at 1 and 2 weeks after retinal ischemia.
Iba1
As shown in Fig. 7 , slightly enhanced coverage of Iba1 was found in the injured ON and OT 2 weeks after retinal ischemia. This elevation of Iba1 reached significance (4-fold increase) after 4 weeks in both the ON and OT.
DISCUSSION
Decreases in k k followed by increases in k ? have been reported to detect axonal and myelin damage in white matter with axonal degeneration. 6, 25, 31 Using WldS mice, we also observed the same DTI changes in ON and OT after retinal ischemia. The damage to axons followed by a colocated myelin loss were detected by DTI and confirmed by histology. This pattern of observed DTI changes reveals the temporal evolution of pathology during and following acute axonal degeneration. The same array of DTI changes have also been reported in humans during Wallerian degeneration, [8] [9] [10] [11] suggesting some commonalities in axonal degeneration across diseases and species. In addition to characterizing the temporal evolution of axonal degeneration, it is also important to understand its spatial evolution. Both ON and OT contain axons originated from the same neuronal cells in retina. We have previously attempted to use DTI to track degeneration in the ON and OT after retinal ischemia. Using wildtype mice, we found that both the ON and OT exhibited axon disruption concurrently 3 days after retinal ischemia. 6, 25, 31 This rapid degeneration did not allow us to differentiate the regional variation between the ON and OT. This fast form of degeneration in mice may not reflect the slower process of axonal degeneration in the human central nervous system (CNS). 5, 32 In our experiment using WldS mice, the axonal damage in the OT (the distal portion of RGC axons) was detected a week after axonal damage in the ON (a proximal portion of RGC axons), suggesting anterograde degeneration propagating from cell bodies toward the axonal terminals. From our MRI data, we estimate the distance from the retina to the ON ROI to be 4 mm, which is roughly equal to the distance between the ON ROI and the OT ROI. We estimate the speed of degeneration to be roughly 0.57 mm per day (8 mm / 2 weeks for degeneration arrived at OT, which is equal to 4 mm / 1 week for degeneration arrived at ON).
Several studies have attempted to characterize the spatial-temporal profile of axonal degeneration. In vitro work by George and Griffin 4 examined granular disintegration of the cytoskeleton in a rat dorsal radiculotomy model and estimated a degeneration speed of 3 mm/hr along axons emanating from the initial damage sites. Data by Ozturk et al 3 supports the idea that there are distinct axonal degeneration patterns, either with fragmentation or retraction steps during dying-back degeneration. These patterns were related to the survival or death of the neuronal cells. 3 As such, different spatial patterns of axonal degeneration may represent pathways critical to neuronal fate in neurodegenerative conditions. Our study does not intend to predict axonal degeneration rates in humans based on our animal data. Instead, our study illustrates the possibility of using longitudinal DTI to characterize ongoing axonal degeneration and to differentiate subtypes of neurodegenerative conditions. This characterization may allow for differentiation from occurrences of "dying back" degeneration, which has been implicated in several diseases including amyotrophic lateral sclerosis (ALS). 33 In MS, Gd-T 1 WI is routinely used to detect active inflammatory lesions. While focal damage can precipitate axonal degeneration towards remote brain areas, white matter with axonal degeneration is generally considered to appear normal without enhancement on Gd-T 1 WI. 21, 22 As predicted, we found no visible enhancement within the injured ON and OT after retinal ischemia. However, when the tissue was examined using Evans blue, higher signal was observed, suggesting an infiltration and accumulation of serum albumin into the damaged white matter. To explain this, we note that several studies have confirmed that extensive inflammatory activities exist in damaged white matter without causing enhancement on Gd-T 1 WI. 34, 35 Albumin is long known to be one of the acute-phase proteins in response to inflammation. 36 As its key functions involve wound healing, 37 we speculate that albumin may be transported into the injured sites for tissue repair. Previous studies have suggested that microglia/macrophage activity in axonal degeneration within the CNS is delayed compared to degeneration in the peripheral nervous system (PNS). 4, 22, 38 As such, the delayed microglia/macrophage activity in our study did not surprise us. It is noted that even when significant microglia/macrophage activity was detected at the final timepoint, there was still no BBB leakage detectable by Gd-T 1 WI. Our data supports the view that BBB permeability remains low in white matter with extensive axonal degeneration and inflammation. According to our results, it seems likely that Gd-T 1 WI can specifically detect initial autoimmune lesions in MS without confounding factors from secondary axonal degeneration. While our study demonstrates the capability of DTI to characterize the temporospatial profile of axonal degeneration, limitations must be considered before generalizing our results to other model systems and human disease. Our study was conducted using WldS mice, which show delayed axonal degeneration. 39, 40 This form of degeneration is more gradual than the rapid process in wildtype mice and may reflect different underlying mechanisms. Considerations of our procedure are also relevant to interpreting the results. Within our experimental procedure, ROI selections were made by two experienced operators manually. Studies using more objective approaches, such as automatic white matter segmentation, 41 as well as with a larger amount of samples, may provide data to better describe the temporospatial profiles of degeneration. Further research is required for understanding to what degree our findings can be generalized to other white matter pathways in wildtype mice and in conditions of human disease.
In conclusion, using longitudinal DTI on ON and OT of mice after retinal ischemia, decreased k k followed by increased k ? were observed and these changes were associated with the axonal damage followed by myelin loss. The early ON damage followed by OT damage shows the spatial evolution of axonal degeneration that propagates from cell bodies to distal axonal terminals. Injured white matter within the ON and OT appear normal on Gd-T 1 WI, which is consistent with clinical findings in MS. While the BBB remains tight, infiltration and accumulation of albumin detectable by Evans blue suggests an early inflammatory response in the degenerating nerves.
